Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin versus pravastatin crossover study in dysbetalipoproteinemia
2005-002889-11Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rosuvastatin and pravastatin in dysbetalipoproteinemia (DBL) (4 arms), sponsored by AstraZeneca. Started Sep 2005; status: completed.
02
Drugs
rosuvastatinpravastatin
03
Conditions
dysbetalipoproteinemia (DBL)
Beyond the preview
Go deeper on 2005-002889-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002889-11.